VA
GRDN icon

Vident Advisory’s Guardian Pharmacy Services GRDN Stock Holding History

Vident Advisory’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$573K Buy
13,689
+980
+8% +$37.9K ﹤0.01% 1292
2026
Q1 		$479K Buy
+12,709
New +$415K ﹤0.01% 1282

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Vident Advisory's GRDN Position: Q2 2026 in Review

Vident Advisory increased its Guardian Pharmacy Services (GRDN) stake by 7.7% in Q2 2026, buying an estimated $37.9K and bringing the position to 13,689 shares worth $573K. The position accounts for ﹤0.01% of the portfolio, ranked #1292.

Vident Advisory first reported a position in GRDN in Q1 2026 and has held it in 2 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Vident Advisory held 13,689 shares of Guardian Pharmacy Services worth $573K as of Q2 2026.
  • Vident Advisory bought 980 Guardian Pharmacy Services shares in Q2 2026, an estimated $37.9K.
  • Guardian Pharmacy Services made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1292 holding.
  • Vident Advisory first reported a position in Guardian Pharmacy Services in Q1 2026 and has held it in 2 quarters since.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.